USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A New Era in Human Health to Resolve Unmet Medical Needs
05-May-2014
North America
Market Research
MA1E-01-00-00-00
LS00100-NA-MR_16941
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.
Executive Summary
Executive Summary (continued)
Regenerative Medicine Market—Game-changing Strategies
Methodology and Scope
Introduction
Introduction (continued)
Introduction (continued)
Market Overview—Segmentation
Market Overview—Cell Therapy (CT)Segment
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Gene Therapy (GT) Segment
Market Overview—Tissue Engineering (TE) Segment
Market Overview—Small Molecules and Biologics Segment
Cell Therapy—Competitive Landscape of Marketed Products
Cell Therapy—Competitive Landscape of Products in Development
Cell Therapy—Market Segmentation
Cell Therapy—Marketed Products Synopsis
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Product Dashboard—Apligraf (Organogenesis)
Product Dashboard—GINTUIT (Organogenesis)
Product Dashboard—Provenge (Dendreon)
Product Dashboard—Grafix (Osiris Therapeutics)
Product Dashboard—Dermagraft (Shire)
Product Dashboard—Osteocel Plus (NuVasive)
Product Dashboard—ReCell Spray-On Skin (Avita Medical)
Product Dashboard—Trinity Evolution (Orthofix)
Product Dashboard—BioDfactor (BioD, LLC)
Product Dashboard—BioDfence (BioD, LLC)
Cell Therapy—Pipeline Synopsis
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy—Pipeline Breakdown
Company—Aastrom Biosciences, Inc.
Company—Advanced Cell Technology, Inc.
Company—Aldagen, Inc. (Acquired by Cytomedix)
Company—Athersys, Inc.
Company—Celgene Cellular Therapeutics
Company—Cellerant Therapeutics, Inc.
Company—Gamida Cell Ltd.
Company—Garnet BioTherapeutics
Company—Histogenics
Company—Mesoblast Ltd.
Company—Neuralstem, Inc.
Company—Osiris Therapeutics, Inc.
Company—Pluristem Therapeutics, Inc.
Company—SanBio, Inc.
Company—StemCells, Inc.
Company—TCA Cellular Therapy, LLC
Company—TiGenix NV
Gene Therapy Overview
Gene Therapy Overview (continued)
Gene Therapy Overview (continued)
Key Company to Watch—Juventas Therapeutics Inc.
Tissue Engineering Overview
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Small Molecules and Biologics Overview
Small Molecules and Biologics Overview (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Vascular Disease Regenerative Medicine Market
Vascular Disease Regenerative Medicine Market (continued)
Non-Healing Wounds Regenerative Medicine Market
Non-Healing Wounds Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market
Spinal Cord Injury Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market (continued)
Alzheimer’s Disease Regenerative Medicine Market
Alzheimer’s Disease Regenerative Medicine Market (continued)
Parkinson’s Disease (PD) Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market (continued)
Musculoskeletal Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market
Autoimmune Disorders Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market (continued)
Stroke Regenerative Medicine Market
Stroke Regenerative Medicine Market (continued)
Diabetes Regenerative Medicine Market
Diabetes Regenerative Medicine Market (continued)
Ocular Diseases Regenerative Medicine Market
Ocular Diseases Regenerative Medicine Market (continued)
Regenerative Medicine Market—Timeline of Key Events
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Conclusions and Recommendations
Legal Disclaimer
Human Embryonic Stem Cells Overview
Mesenchymal Stem Cells Overview
Neural Stem Cells Overview
Induced Pluripotent Stem Cells Overview
Stem Cell Types in Development
List of Abbreviations
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aiswariya Chidambaram |
| WIP Number | MA1E-01-00-00-00 |
| Is Prebook | No |
Global Regenerative Medicine Market
$3,950.00
Special Price $2,962.50 save 25 %